OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery.
Our Head of Molecular Technologies, Dr Martin Main, has been invited to serve as a member of the SLAS Discovery Editorial Board.
Innovate UK, as part of UK Research and Innovation, is looking to support female rising stars in business innovation.
Medicines Discovery Catapult has appointed Dr Robin Brown as its new Chairman.
CEO, Chris Molloy, was awarded Membership of the Institute of Cancer Research (ICR) at a ceremony in London.
CBSO, Mark Samuels, had a Letter to the Editor published in The Times.
Health Secretary Matt Hancock officially opened the biggest diagnostic lab network in British history.
CEO, Chris Molloy, discusses the role of Medicines Discovery Catapult within the UK as a centre for applied medical R&D.
Pharmaphorum’s Deep Dive magazine “Future Pharma” focuses on the predictions for healthcare and the drug development process.
Business Secretary Greg Clark launched the Rosalind Franklin Institute.
See how we can help support you with your next drug discovery project.
Speak to us